GENE ONLINE|News &
Opinion
Blog

Sanofi
GeneOnline’s Pick: Top 10 Global Industry News Stories in 2023 (Part 1)
2024-01-08
Reviewing the Market Trends in the Antibody-Drug Conjugate Development: A Focus on Roche, Sanofi, BMS, Seagen, and BioNTech
2024-01-05
Sanofi Inks Two Major Strategic R&D Collaborations in a Single Week
2023-07-24
GeneOnline’s Weekly News Highlights: July 17-21
2023-07-24
Sanofi and AstraZeneca’s RSV Antibody Drug Gets FDA Approval, Adding New Weapon for Preventing Infant Infections
2023-07-18
Sanofi Goes “All In” to Lead the AI Revolution in Pharmaceutical Industry
2023-06-18
GeneOnline’s Weekly News Highlights: June 12-16
2023-06-17
Sobi Enters Into New Royalty Agreement on RSV Antibody Drug Nirsevimab With Sanofi
2023-04-11
Sanofi Slashes Insulin Prices by Up to 78% Following Hot On the Heels of Major Competitors
2023-03-19
FDA Approves Sanofi and Sobi’s Once-Weekly Hemophilia A Med
2023-02-23
Sanofi, GSK Secure European COVID-19 Booster Approval, AstraZeneca Withdraws U.S. Application
2022-11-10
Insilico Makes its Biggest AI Deal Ever with Sanofi for Potential $1.2 Billion
2022-11-09
Sanofi, miRecule To Develop Muscular Dystrophy Candidate In $400+ Million Partnership
2022-10-05
Sanofi and Regeneron’s Dupixent Snags its Tenth Approval From the FDA
2022-09-29
AstraZeneca, Sanofi’s RSV Antibody Recommended For Approval In EU
2022-09-19
1 2 3 4
LATEST
Why NVIDIA’s CEO Huang Said AI Fostering Life Science:Highlighting GPU’s Applications in Biotech
2024-02-23
Revolutionary AI-Powered Respiratory Monitor Maker Gets Financial Boost with Latest Funding
2024-02-21
Researchers Predict Drug Interactions with Machine Learning to Enhance Patient Safety
2024-02-21
USC-Led Study Reveals Benefits of Fasting-Mimicking Diet in Reducing Disease Risk and Slowing Aging
2024-02-21
Astonishing brain tumour research wins the BIAL Award in Biomedicine 2023 worth 300,000 Euro
2024-02-21
Targeted Cancer Therapy Breakthrough: Degrader-Antibody Conjugates (DACs) Advance to Clinical Trials
2024-02-19
Degrader-Antibody Conjugates (DACs): Targeted Degradation for Therapeutics
2024-02-19
EVENT
Scroll to Top